Fifth Third Bancorp Supernus Pharmaceuticals, Inc. Transaction History

Fifth Third Bancorp

  • $27.3 Billion
  • Q3 2024

A detailed history of Fifth Third Bancorp transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Fifth Third Bancorp holds 272 shares of SUPN stock, worth $9,675. This represents 0.0% of its overall portfolio holdings.

Number of Shares
272
Previous 265 2.64%
Holding current value
$9,675
Previous $7,000 14.29%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024
BUY
$25.77 - $35.16 $180 - $246
7 Added 2.64%
272 $8,000
Q2 2024

Jul 22, 2024
BUY
$25.99 - $33.85 $727 - $947
28 Added 11.81%
265 $7,000
Q1 2024

Apr 23, 2024
BUY
$27.11 - $35.17 $325 - $422
12 Added 5.33%
237 $8,000
Q4 2023

Jan 19, 2024
BUY
$22.72 - $29.68 $2,976 - $3,888
131 Added 139.36%
225 $6,000
Q3 2023

Oct 31, 2023
SELL
$27.57 - $32.91 $1,736 - $2,073
-63 Reduced 40.13%
94 $2,000
Q2 2023

Jul 25, 2023
BUY
$29.91 - $38.73 $2,841 - $3,679
95 Added 153.23%
157 $4,000
Q4 2022

Jan 25, 2023
BUY
$31.09 - $37.88 $1,088 - $1,325
35 Added 129.63%
62 $0
Q2 2022

Aug 04, 2022
SELL
$25.33 - $34.25 $6,180 - $8,357
-244 Reduced 90.04%
27 $1,000
Q1 2022

Apr 19, 2022
SELL
$28.51 - $32.9 $171 - $197
-6 Reduced 2.17%
271 $9,000
Q4 2021

Feb 01, 2022
BUY
$26.37 - $34.22 $5,353 - $6,946
203 Added 274.32%
277 $8,000
Q3 2021

Oct 15, 2021
BUY
$23.54 - $31.39 $1,741 - $2,322
74 New
74 $2,000
Q1 2021

May 07, 2021
SELL
$24.15 - $31.45 $4,588 - $5,975
-190 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$17.7 - $25.81 $3,363 - $4,903
190 New
190 $5,000
Q2 2020

Aug 05, 2020
SELL
$17.09 - $24.89 $1,914 - $2,787
-112 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$19.93 - $29.13 $2,232 - $3,262
112 New
112 $3,000
Q3 2018

Nov 14, 2018
SELL
$42.7 - $56.55 $458,512 - $607,233
-10,738 Closed
0 $0
Q2 2018

Aug 14, 2018
SELL
$44.1 - $59.85 $119,114 - $161,654
-2,701 Reduced 20.1%
10,738 $643,000
Q1 2018

May 15, 2018
SELL
$37.15 - $46.9 $61,966 - $78,229
-1,668 Reduced 11.04%
13,439 $616,000
Q4 2017

Feb 14, 2018
BUY
$36.4 - $42.6 $128,164 - $149,994
3,521 Added 30.39%
15,107 $602,000
Q3 2017

Nov 14, 2017
SELL
$36.75 - $49.65 $144,207 - $194,826
-3,924 Reduced 25.3%
11,586 $463,000
Q2 2017

Aug 11, 2017
BUY
N/A
15,510
15,510 $668,000

Others Institutions Holding SUPN

# of Institutions
282
Shares Held
61.1M
Call Options Held
27.7K
Put Options Held
11.3K
View Full List

About SUPERNUS PHARMACEUTICALS, INC.

SUPN Quotes by TradingView
  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $1.9B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Fifth Third Bancorp Portfolio

Follow Fifth Third Bancorp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email